Document:

EXHIBIT 10.11

 

STOCK PURCHASE AGREEMENT

 

This Stock Purchase Agreement is dated as of this 25" day
of March, 2019 by and between Matthew Wolfson (the ASeller”) and Petar Gajic (the “Buyer’).

 

WHEREAS, the Buyer is an employee of Electromedical Technologies,
Inc., a Delaware company (the “Company”); and

 

WHEREAS, previously, the Seller had orally agreed to sell 500,000
of his shares of the Company (the “Shares”) to the Buyer for the par price per share which Seller paid for his shares
of the Company; and

 

WHEREAS, the Seller and Buyer agree that it is in their best
interest to memorialize in writing the sale of the Shares.

 

NOW THEREFORE, in consideration of
the mutual promises, covenants, representations and warranties contained herein, and other good and valuable consideration,
and with the intent that, upon consummation of the transactions contemplated herein, and upon the terms set forth herein the
parties hereby agree to as follows:

 

	1.	The Seller agrees to sell, and Buyer agrees to purchase, the Shares for $50.00.

 

	2.	Seller represents that he has good and marketable title to the Shares. IN WITNESS WHEREOF, the parties have executed this Agreement
as of the date

 

first written above.

 

SELLER: MATTHEW WOLSON BUYER: PETAR GAJIC.

 

Mathew fson Petar Gajic

 

11-ZU1U

 

Yur I-JIU45

 

Notice to Purchaser - In the event that this check is lost,
misplaced or Cashier's Check - Customer Copy

 

stolen, a sworn statement and 90-day waiting period will be
required prior to replacement This check should be negotiated within 90 days

 

Void After 90 Days

 

                                                                     

 

                                                        

 

Fifty and 00/100 Dollars ToThe MATTHEW WOLFSON

 

     

     

    

 

Order Of 500,000 SHARES PURCHASE Remitter (Purchased By): PETAR
GAJIC

 

Bank of America, N.A. PHOENIX, AZExhibit 10.12

 

CONSENT ACTION OF
THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC.

 

The
undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”),
hereby unanimously consent to the following actions taken on Company on October 11, 2019.

 

RESOLVED:
To issue Iakovos Tsakalidis (“Tsakalidis”) a total of 80,282 shares of the Company’s restricted common stock
in full and complete satisfaction of any and all claims which Tsakalidis may have against the Company pursuant to that certain
Promissory Note by and between Tsakalidis and the Company dated December 31, 2015. The total amount owed to Tsakalidis was $57,000.00
and the shares are valued at $0.71 per share.

 

RESOLVED:
That the Company’s transfer agent, Pacific Stock Transfer, is hereby authorized to issue the foregoing shares to Tsakalidis
at the following address: 6940 E. DoubleTree Ranch Rd., Paradise Valley, AZ 85253.

 

There
being no further business requiring board action or consideration, on motion duly made, and carried, the meeting was adjourned.

 

 

 

Matthew N. Wolfson

Sole DirectorExhibit 10.15

 

CONSENT ACTION OF
THE BOARD OF DIRECTORS OF

ELECTROMEDICAL TECHNOLOGIES, INC.

 

The
undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”),
hereby unanimously consent to the following actions taken on Company on October 11, 2019.

 

RESOLVED:
To issue Nikolai Ogorodnikov (“Ogorodnikov”) a total of 63,380 shares of the Company’s restricted common stock
in full and complete satisfaction of any and all claims which Ogorodnikov may have against the Company the pursuant to that certain
Promissory Note by and between Ogorodnikov and the Company dated October 31, 2013. The total amount owed to Ogorodnikov was $45,000
and the shares are valued at $0.71 per share.

 

RESOLVED:
That the Company’s transfer agent, Pacific Stock Transfer, is hereby authorized to issue the foregoing shares to Ogorodnikov
at the following address: 228 S. Doheny Dr., Apt. #4, Beverly Hills, CA 90211.

 

There
being no further business requiring board action or consideration, on motion duly made, and carried, the meeting was adjourned.

 

 

Matthew N. Wolfson

Sole DirectorExhibit 10.17

 

CONSENT ACTION OF
THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC.

 

The
undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”),
hereby unanimously consents to the following actions taken by the Company on October 11, 2019.

 

RESOLVED:
To confirm the Consulting Agreement with PYP Enterprises dated July 1, 2019 by and between the Company and PYP Enterprises
and to issue PYP Enterprises 10,000 shares of the Company restricted common stock valued at $0.71 per share.

 

RESOLVED:
That Pacific Stock Transfer is hereby instructed to issue 10,000 shares of the Company’s restricted common stock to PYP Enterprises,
370 Melbourne Glen, Escondido, CA, 92026.

 

There
being no further business requiring board action or consideration, on motion duly made, and carried, the meeting was adjourned.

 

	 

Matthew N. Wolfson

Sole DirectorExhibit 10.18

 

Consulting
Agreement

 

This
consulting agreement (the “Agreement”) is made and entered on this day 1st day of July, 2019 (the “Effective
Date”) by and between PYP Enterprises (hereinafter referred to as the “Consultant”) and Electromedical Technologies,
Inc. (hereinafter referred to as the “Client”).

 

	1.	Services

 

The
Consultant will provide strategic business services to the Client, which may include: Assisting with the Compensation Plan, Consulting
on MLM program, Website design and SEO consulting.

 

 

	2.	Compensation and Reimbursement
                                         of Expenses

 

The
Client agrees to pay the Consultant a fixed fee of ten thousand (10,000) r e st r ic t e d common shares for the services provided.
This fee shall cover services pursuant to Section 1 of this Agreement. The total amount owed per this agreement shall be deemed
earned in full on September 30, 2019. For purposes of this agreement, the shares are va1ued at $0.71 per share.

 

The
Consultant will maintain adequate documentation and records to support all costs invoiced to the Client including receipts for
travel related expenses however, such expenses must be approved by the Client prior to being incurred by Consultant.

 

Payments
made by the Client to the Consultant will not deduct any taxes and the Client will provide the Consultant with IRS Form 1099 at
the end of each calendar year. For purposes of issuing IRS Form 1099, the Consultant will provide a social security number upon
execution of his agreement.

 

The
shares of Common Stock provided for a compensation to Consultant may not be sold or transferred unless:

 

(i)
such shares are sold pursuant to an effective registration statement under the Act or (ii) the Consultant or its transfer agent
shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions
of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant
to an exemption from such registration (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor
rule) (“Rule 144”).

 

The
certificate for shares of Common Stock has not been so included in an effective registration statement or that has not been sold
pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend substantially
in the following form, as appropriate:

 

     

     

    

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HA VE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

	3.	Term and Termination

 

This
agreement will commence on the effective date set forth and continue for a period of t h r e e months from the effective date
unless terminated earlier. Either party may terminate this agreement at any time upon thirty-day (30) notification. The Client
may at its option agree to renew, extend and revise this agreement prior to its expiration.

 

	4.	Confidential Information

 

Both
parties acknowledge that there is an exchange of confidential and proprietary information associated with this agreement. Confidential
and proprietary information may include documents, communications, plans, processes, formulations, data, know-how, financial information,
techniques, methods, customers, suppliers, partners, patents, trademarks, designs, and other forms of tangible or intangible artifacts
owned by the Client. Confidential and proprietary information does not include information within the public domain, information
that has been publicly known prior to the execution of this agreement, or information that the Consultant developed independent
of any confidential information.

 

The
Consultant will not divulge, disseminate, publish or otherwise disclose any information without the prior consent of the Client.
The Consultant will not use any information for purposes other than the performance of services described in this agreement. The
Client agrees to not disclose confidential information to the Consultant except to the extent that the Consultant requires this
information to fulfill the obligations within this agreement.

 

If
the Client has any concerns over the sharing of sensitive information and requires additional control measures, the Consultant
will establish secured means of information sharing that are mutually agreeable to both parties. These control measures may include
restricting who can copy, print, or change documents during the course of the engagement.

 

     

     

    

 

	5.	Indemnification

 

Notwithstanding
other provisions of this agreement, the Client shall indemnify, defend and hold harmless the Consultant against claims, liabilities,
damages, losses or other obligations, which may arise from this agreement.

 

	6.	Relationship of Parties

 

The
parties agree that this agreement creates an independent contractor relationship, not an employment relationship. Neither party
is, nor shall claim to be, a legal agent, representative, partner, or employee of the other, and neither shall have the right
or authority to contract in the name of the other, nor shall it assume or create any obligations, debts, accounts or liabilities
for the other.

 

	7.	Role of the Consultant

 

The
Consultant will not make management decisions on behalf of the Client. The role of the Consultant shall be advisory in nature
with no perceived conflicts of interest prior to, during or after the engagement with the Client. This role will also extend to
any third parties that the Consultant may use during the course of the engagement.

 

	8.	Reliance on Client Provide
                                         Information

 

Regarding
any information or material that the Company furnishes to Consultant or any other entity in connection with this Agreement, the
Company acknowledges and confirms that (i) Consultant will use and rely on such information and material without independently
verifying the same, (ii) Consultant does not assume responsibility for the accuracy or completeness of any of the information
or material, (iii) Consultant will not make any appraisal, evaluation or independent determination regarding such information
or material or the Company and (iv) Consultants shall not have any liability in connection with such information or material.
The Company represents to Consultant that the information and material to be furnished by the Company, when delivered, will be
true, complete and correct in all material respects and will not contain any material misstatement of fact or omit to state any
material fact necessary to make the statements contained therein not misleading. The Company shall promptly notify Consultants
if it learns of any material inaccuracy or misstatement in, or material omission from, any information or material delivered to
Consultant.

 

	9.	Quality Assurance and
                                         Control

 

In
an effort to ensure that the Consultant provides high quality work, the Client will assign the CEO of the Client company to review
and approve the work of the Consultant. In the event that the Consultant uses a third party, the Consultant is responsible for
the quality of the work delivered by the third party.

 

     

     

    

 

	10.	Non-Agent of Client

 

It
is understood that Consultant is not acting as agent or fiduciary of, and have no liabilities to, the equity holders of the Company
or any other third party in connection with this Agreement or any introductions, services or transactions hereunder, all of which
liabilities are expressly waived.

 

	11.	Clawback

 

The
compensation granted under this agreement are subject to the terms of the client’s recoupment, clawback or similar policy
as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances
(e.g. failure to perform throughout the term, gross negligence, violation of State laws, violation of SEC regulations) require
repayment or forfeiture of compensation or any shares of Common Stock or other cash or property received.

 

	12.	Governing Law

 

This
Agreement shall be governed by and interpreted in accordance with the laws of the state of A r i z o n a applicable to agreements
negotiated, executed and to be performed in the state, without regard to the choice or conflicts of law rules or principles of
that state. The parties hereto hereby consent to the jurisdiction of the state courts located in Scottdale, Arizona, over the
parties and any disputes, claims, actions, suits and proceeding relating to this agreement or the transactions contemplated herein.

 

	13.	NOTICES. All
                                         notices to be furnished pursuant to this Agreement shall be by email as follows:

 

If
to the Client: Matthew Wolfson

Email: CEO@electromed.com

 

With
a copy to:

 

Eric P. Littman, Esquire

Email: littmanlaw@gmail.com

 

If
to Consultant:

 

PYP
Enterprises

Email:
cgmusc@gmail.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]